Prometheus Biosciences Inc, a United States-based biopharmaceutical company, has named Keith Marshall, PhD, MBA as its new chief financial officer, it was reported on Tuesday.
In the new role, Marshall will serve on the executive management team and will head the firm's finance and investor relations functions.
Prior to joining Prometheus, Marshall was executive vice president, chief operating officer and chief financial officer of Conatus Pharmaceuticals. He has also held the position of chief financial officer and head of Corporate Development at Torque Therapeutics, managing director in Healthcare Investment Banking at GCA Savvian Advisors, managing director, co-founder, and chief financial officer at Montgomery, Marshall Healthcare Partners, and managing director of Healthcare Investment Banking at Montgomery & Co.
Nuevocor names new chief medical officer
ELIAS Animal Health names new chief revenue officer
enGene Holdings names new senior vice president, Urologic Oncology and Clinical Development
HealthTrackRx names new chief medical officer
PureTech announces launch of Seaport Therapeutics with USD100m Series A financing
REVIAN names new vice president of Healthcare Sales
Orsini Specialty Pharmacy names new CFO and EVP of Trade Relations and Account Management
Ligand Pharmaceuticals launches Pelthos Therapeutics to drive ZELSUVMI commercialisation
Soligenix announces agreement on design for second Phase 3 trial for HyBryte with EMA
Ratio Therapeutics names new chief business officer and director
Trevi Therapeutics names new vice president of Clinical Development
NeoImmuneTech names new president and chief executive officer